Australia’s metastatic breast cancer data gains global attention at major conference

Australia’s metastatic breast cancer data gains global attention at major conference

13 May 2026

At the event, Breast Cancer Network Australia (BCNA) shared its method for estimating how many Australians are living with metastatic breast cancer. The approach uses health system data to identify people living with the disease, not just new diagnoses.

BCNA says understanding these numbers is important for health planning, so services can better meet treatment and support needs across Australia.

The work was presented by BCNA’s Director of Policy and Advocacy, Vicki Durston, and received strong international interest. The goal is for other countries to use similar methods to better track metastatic breast cancer in their own populations.

Advocates say making this group visible in data is important, as people with metastatic breast cancer are living longer due to treatment advances, but still face gaps in care and support.

The presentation also highlighted that recognising this group helps improve health system planning and decision-making.

The ESMO conference also focused on rapid changes in breast cancer treatment, including more personalised care based on tumour biology, genetic testing, and new targeted therapies.

Experts noted a growing gap between medical advances and patient access to treatment, influenced by funding systems, affordability, and access to diagnostic tests.

For Australian patients, these issues directly affect access to treatments through systems like the Pharmaceutical Benefits Scheme and public health services.

BCNA says international collaboration helps strengthen advocacy in Australia, supporting efforts to improve access to evidence-based breast cancer care and ensure more equitable treatment options.

https://www.bcna.org.au/

Source: Breast Cancer Network Australia (BCNA) / ESMO Conference

Categories

Popular Posts

Recent Posts

Tags